相关实验视频

Updated: Jul 30, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

耗尽的T细胞签名在泛癌环境中的表征

Rifat Tasnim Juthi^1,2, Saiful Arefeen Sazed², Manvita Mareboina²

¹Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka 1000, Bangladesh.

International journal of molecular sciences

|March 13, 2025

概括

在癌症免疫学和免疫治疗中,T细胞耗尽 (Tex) 标志物至关重要. 恢复枯竭的T细胞可以提高抗癌治疗的疗效.

科学领域:

癌症免疫学和免疫疗法
分子瘤学分子瘤学
基因组学和生物信息学

背景情况:

T细胞在癌症中具有多方面的作用,包括瘤抑制和免疫逃避.
癌细胞可以诱导T细胞耗尽,损害抗瘤免疫反应.
耗尽的T细胞 (Tex) 标记是瘤免疫微环境 (TME) 的关键调节者.

研究的目的:

在多种癌症中系统地研究六种已知的Tex标记物的作用 (LAG-3,PDCD1,TIGIT,HAVCR2,CXCL13,LAYN).
探索它们的分子相互作用,突变特征以及对癌症免疫疗法的影响.
分析与患者生存,癌症相关途径,免疫透和药物敏感性的关联.

主要方法:

使用TCGA,GEO和TCPA的泛癌mRNA表达数据.
标志着Tex标志物的差异表达,生存关联和突变概况.
分析了对癌症途径,免疫细胞透和抗癌药物敏感性的影响.

主要成果:

所有六个Tex标记物的差异表达与KIRC和多种癌症的不良预后有显著关联.
德克斯标记物显示出在亡,EMT和激素ER途径中的潜在作用,以及在DNA损伤反应和RTK途径中的抑制作用.
免疫细胞透与大多数癌症类型的Tex标记基因表达相关.

结论:

德克斯标记物的表达与癌症预后和免疫逃避机制有显著联系.
恢复耗尽的T细胞是一个有前途的策略,可以提高癌症患者的免疫疗法疗效.
了解Tex标记者的作用为开发新型免疫治疗方法提供了洞察力.

关键词:

T细胞耗尽的情况药物敏感性药物敏感性已经耗尽的T细胞标记物基因表达的基因表达方式免疫透免疫透是什么?甲基化处理甲基化处理进行多主题分析.突变景观的变化胰腺癌是一种癌症.

更多相关视频

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...